References
- Akbaba, Y., Türkeş, C., Polat, L., Söyüt, H., Sahin, E., Menzek, A., Göksu, S., & Beydemir, S. (2013). Synthesis and paroxonase activities of novel bromophenols. Journal of Enzyme Inhibition and Medicinal Chemistry, 28(5), 1073–1079. https://doi.org/https://doi.org/10.3109/14756366.2012.715287
- Alım, Z., Kılıç, D., & Demir, Y. (2019). Some indazoles reduced the activity of human serum paraoxonase 1, an antioxidant enzyme: In vitro inhibition and molecular modeling studies. Archives of Physiology and Biochemistry, 125(5), 387–395. https://doi.org/https://doi.org/10.1080/13813455.2018.1470646
- Aslan, H. E., Demir, Y., Özaslan, M. S., Türkan, F., Beydemir, Ş., & Küfrevioğlu, Ö. I. (2019). The behavior of some chalcones on acetylcholinesterase and carbonic anhydrase activity. Drug and Chemical Toxicology, 42(6), 634–640. https://doi.org/https://doi.org/10.1080/01480545.2018.1463242
- Beydemir, Ş., & Demir, Y. (2017). Antiepileptic drugs: Impacts on human serum paraoxonase‐1. Journal of Biochemical and Molecular Toxicology, 31(6), e21889. https://doi.org/https://doi.org/10.1002/jbt.21889
- Beydemir, Ş., Türkeş, C., & Yalçın, A. (2019). Gadolinium-based contrast agents: In vitro paraoxonase 1 inhibition, in silico studies. Drug and Chemical Toxicology, 1–10. https://doi.org/https://doi.org/10.1080/01480545.2019.1620266
- Bradford, M. M. (1976). A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Analytical Biochemistry, 72(1–2), 248–254. https://doi.org/https://doi.org/10.1016/0003-2697(76)90527-3
- Caglayan, C., Demir, Y., Kucukler, S., Taslimi, P., Kandemir, F. M., & Gulçin, İ. (2019a). The effects of hesperidin on sodium arsenite‐induced different organ toxicity in rats on metabolic enzymes as antidiabetic and anticholinergics potentials: A biochemical approach. Journal of Food Biochemistry, 43(2), e12720. https://doi.org/https://doi.org/10.1111/jfbc.12720
- Caglayan, C., Taslimi, P., Türk, C., Kandemir, F. M., Demir, Y., & Gulcin, İ. (2019b). Purification and characterization of the carbonic anhydrase enzyme from horse mackerel (Trachurus trachurus) muscle and the impact of some metal ions and pesticides on enzyme activity. Comparative Biochemistry and Physiology. Toxicology & Pharmacology : CBP, 226, 108605. https://doi.org/https://doi.org/10.1016/j.cbpc.2019.108605
- Ceylan, H., Demir, Y., & Beydemir, Ş. (2019). Inhibitory effects of usnic and carnosic acid on some metabolic enzymes: An in vitro study. Protein & Peptide Letters, 26(5), 364–370. https://doi.org/https://doi.org/10.2174/0929866526666190301115122
- Chistiakov, D. A., Melnichenko, A. A., Orekhov, A. N., & Bobryshev, Y. V. (2017). Paraoxonase and atherosclerosis-related cardiovascular diseases. Biochimie, 132, 19–27. https://doi.org/https://doi.org/10.1016/j.biochi.2016.10.010
- Demir, Y., Şenol Kotan, M., Dikbaş, N., & Beydemir, Ş. (2017). Phytase from Weissella halotolerans: Purification, partial characterisation and the effect of some metals. International Journal of Food Properties, 20(sup2), 2127–2137. https://doi.org/https://doi.org/10.1080/10942912.2017.1368547
- Demir, Y. (2019). The behaviour of some antihypertension drugs on human serum paraoxonase-1: An important protector enzyme against atherosclerosis. Journal of Pharmacy and Pharmacology, 71(10), 1576–1583. https://doi.org/https://doi.org/10.1111/jphp.13144
- Demir, Y. (2020). Naphthoquinones, benzoquinones, and anthraquinones: Molecular docking, ADME and inhibition studies on human serum paraoxonase‐1 associated with cardiovascular diseases. Drug Development Research, 81(5), 628–636. https://doi.org/https://doi.org/10.1002/ddr.21667
- Demir, Y., & Beydemir, Ş. (2015). Purification, refolding, and characterization of recombinant human paraoxonase-1. Turkish Journal of Chemistry, 39(4), 764–776. https://doi.org/https://doi.org/10.3906/kim-1501-51
- Demir, Y., Dikbaş, N., & Beydemir, Ş. (2018a). Purification and biochemical characterization of phytase enzyme from Lactobacillus coryniformis (MH121153). Molecular Biotechnology, 60(11), 783–790. https://doi.org/https://doi.org/10.1007/s12033-018-0116-1
- Demir, Y., Işık, M., Gülçin, İ., & Beydemir, Ş. (2017). Phenolic compounds inhibit the aldose reductase enzyme from the sheep kidney. Journal of Biochemical and Molecular Toxicology, 31(9), e21936. https://doi.org/https://doi.org/10.1002/jbt.21935
- Demir, Y., & Köksal, Z. (2019). The inhibition effects of some sulfonamides on human serum paraoxonase-1 (hPON1). Pharmacological Reports : PR, 71(3), 545–549. https://doi.org/https://doi.org/10.1016/j.pharep.2019.02.012
- Demir, Y., Özaslan, M. S., Duran, H. E., Küfrevioğlu, Ö. İ., & Beydemir, Ş. (2019). Inhibition effects of quinones on aldose reductase: Antidiabetic properties. Environmental Toxicology and Pharmacology, 70, 103195. https://doi.org/https://doi.org/10.1016/j.etap.2019.103195
- Demir, Y., Taslimi, P., Ozaslan, M. S., Oztaskin, N., Çetinkaya, Y., Gulçin, İ., Beydemir, Ş., & Goksu, S. (2018b). Antidiabetic potential: In vitro inhibition effects of bromophenol and diarylmethanones derivatives on metabolic enzymes. Archiv Der Pharmazie, 351(12), 1800263. https://doi.org/https://doi.org/10.1002/ardp.201800263
- Demir, Y., Türkeş, C., & Beydemir, Ş. (2020). Molecular docking studies and inhibition properties of some antineoplastic agents against Paraoxonase-I. Anti-Cancer Agents in Medicinal Chemistry, 20(7), 887–896. https://doi.org/https://doi.org/10.2174/1871520620666200218110645
- Durgun, M., Türkeş, C., Işık, M., Demir, Y., Saklı, A., Kuru, A., Güzel, A., Beydemir, Ş., Akocak, S., Osman, S. M., AlOthman, Z., & Supuran, C. T. (2020). Synthesis, characterization, biological evaluation and in silico studies of sulfonamide Schiff bases. Journal of Enzyme Inhibition and Medicinal Chemistry, 35(1), 950–962. https://doi.org/https://doi.org/10.1080/14756366.2020.1746784
- Friesner, R. A., Banks, J. L., Murphy, R. B., Halgren, T. A., Klicic, J. J., Mainz, D. T., Repasky, M. P., Knoll, E. H., Shelley, M., Perry, J. K., Shaw, D. E., Francis, P., & Shenkin, P. S. (2004). Glide: A new approach for rapid, accurate docking and scoring. 1. Method and assessment of docking accuracy. Journal of Medicinal Chemistry, 47(7), 1739–1749. https://doi.org/https://doi.org/10.1021/jm0306430
- Greenwood, J. R., Calkins, D., Sullivan, A. P., & Shelley, J. C. (2010). Towards the comprehensive, rapid, and accurate prediction of the favorable tautomeric states of drug-like molecules in aqueous solution. Journal of Computer-Aided Molecular Design, 24(6–7), 591–604. https://doi.org/https://doi.org/10.1007/s10822-010-9349-1
- Gündoğdu, S., Türkeş, C., Arslan, M., Demir, Y., & Beydemir, Ş. (2019). New isoindole‐1, 3‐dione substituted sulfonamides as potent inhibitors of carbonic anhydrase and acetylcholinesterase: Design, synthesis, and biological evaluation. ChemistrySelect, 4(45), 13347–13355. https://doi.org/https://doi.org/10.1002/slct.201903458
- Halgren, T. A., Murphy, R. B., Friesner, R. A., Beard, H. S., Frye, L. L., Pollard, W. T., & Banks, J. L. (2004). Glide: A new approach for rapid, accurate docking and scoring. 2. Enrichment factors in database screening. Journal of Medicinal Chemistry, 47(7), 1750–1759. https://doi.org/https://doi.org/10.1021/jm030644s
- Harder, E., Damm, W., Maple, J., Wu, C., Reboul, M., Xiang, J. Y., Wang, L., Lupyan, D., Dahlgren, M. K., Knight, J. L., Kaus, J. W., Cerutti, D. S., Krilov, G., Jorgensen, W. L., Abel, R., & Friesner, R. A. (2016). OPLS3: A force field providing broad coverage of drug-like small molecules and proteins. Journal of Chemical Theory and Computation, 12(1), 281–296. https://doi.org/https://doi.org/10.1021/acs.jctc.5b00864
- İşgör, M. M., & Beydemir, Ş. (2010). Some cardiovascular therapeutics inhibit paraoxonase 1 (PON1) from human serum. European Journal of Pharmacology, 645(1–3), 135–142. https://doi.org/https://doi.org/10.1016/j.ejphar.2010.07.030
- Işık, M., Akocak, S., Lolak, N., Taslimi, P., Türkeş, C., Gülçin, İ., Durgun, M., & Beydemir, Ş. (2020). Synthesis, characterization, biological evaluation, and in silico studies of novel 1,3-diaryltriazene-substituted sulfathiazole derivatives. Archiv Der Pharmazie, 353, e2000102. https://doi.org/10.1002/ardp.202000102
- Işık, M., Beydemir, Ş., Demir, Y., Durgun, M., Türkeş, C., Nasır, A., Necip, A., & Akkuş, M. (2020). Benzenesulfonamide derivatives containing imine and amine groups: Inhibition on human paraoxonase and molecular docking studies. International Journal of Biological Macromolecules, 146, 1111–1123. https://doi.org/https://doi.org/10.1016/j.ijbiomac.2019.09.237
- Işık, M., Demir, Y., Durgun, M., Türkeş, C., Necip, A., & Beydemir, Ş. (2020c). Molecular docking and investigation of 4-(benzylideneamino)-and 4-(benzylamino)-benzenesulfonamide derivatives as potent AChE inhibitors. Chemical Papers, 74(5), 1395–1405. https://doi.org/https://doi.org/10.1007/s11696-019-00988-3
- Işık, M., Demir, Y., Kırıcı, M., Demir, R., Şimşek, F., & Beydemir, Ş. (2015). Changes in the anti-oxidant system in adult epilepsy patients receiving anti-epileptic drugs. Archives of Physiology and Biochemistry, 121(3), 97–102. https://doi.org/https://doi.org/10.3109/13813455.2015.1026912
- Istrefi, Q., Türkeş, C., Arslan, M., Demir, Y., Nixha, A. R., Beydemir, Ş., & Küfrevioğlu, Ö. I. (2020). Sulfonamides incorporating ketene N,S-acetal bioisosteres as potent carbonic anhydrase and acetylcholinesterase inhibitors. Archiv Der Pharmazie, 353 (6), e1900383. https://doi.org/https://doi.org/10.1002/ardp.201900383
- Jakubowski, H. (2000). Calcium-dependent human serum homocysteine thiolactone hydrolase. A protective mechanism against protein N-homocysteinylation. The Journal of Biological Chemistry, 275(6), 3957–3962. https://doi.org/https://doi.org/10.1074/jbc.275.6.3957
- Kubo, M., Koue, T., Maune, H., Fukuda, T., & Azuma, J. (2007). Pharmacokinetics of aripiprazole, a new antipsychotic, following oral dosing in healthy adult Japanese volunteers: Influence of CYP2D6 polymorphism. Drug Metabolism and Pharmacokinetics, 22(5), 358–366. https://doi.org/https://doi.org/10.2133/dmpk.22.358
- Kuremoto, K., Watanabe, Y., Ohmura, H., Shimada, K., Mokuno, H., & Daida, H. (2003). R/R genotype of human paraoxonase (PON1) is more protective against lipoprotein oxidation and coronary artery disease in Japanese subjects. Journal of Atherosclerosis and Thrombosis, 10(2), 85–92. https://doi.org/https://doi.org/10.5551/jat.10.85
- Laemmli, U. K. (1970). Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature, 227(5259), 680–685. https://doi.org/https://doi.org/10.1038/227680a0
- Langley, M. S., & Sorkin, E. M. (1989). Nimodipine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in cerebrovascular disease. Drugs, 37(5), 669–699. https://doi.org/https://doi.org/10.2165/00003495-198937050-00004
- Lineweaver, H., & Burk, D. (1934). The determination of enzyme dissociation constants. Journal of the American Chemical Society, 56(3), 658–666. https://doi.org/https://doi.org/10.1021/ja01318a036
- Liu, Y., Zhang, M-q., Jia, J-y., Liu, Y-m., Liu, G-y., Li, S-j., Wang, W., Weng, L-p., & Yu, C. (2013). Bioequivalence and Pharmacokinetic Evaluation of Two Formulations of Risperidone 2 mg : An open-label, single-dose, fasting, randomized-sequence, two-way crossover study in healthy male Chinese volunteers. Drugs in R&D, 13(1), 29–36. https://doi.org/https://doi.org/10.1007/s40268-012-0002-4
- Lolak, N., Akocak, S., Türkeş, C., Taslimi, P., Işık, M., Beydemir, Ş., Gülçin, İ., & Durgun, M. (2020). Synthesis, characterization, inhibition effects, and molecular docking studies as acetylcholinesterase, α-glycosidase, and carbonic anhydrase inhibitors of novel benzenesulfonamides incorporating 1,3,5-triazine structural motifs. Bioorganic Chemistry, 100, 103897. https://doi.org/https://doi.org/10.1016/j.bioorg.2020.103897
- Özaslan, M. S., Balcı, N., Demir, Y., Gürbüz, M., & Küfrevioğlu, Ö. İ. (2019). Inhibition effects of some antidepressant drugs on pentose phosphate pathway enzymes. Environmental Toxicology and Pharmacology, 72, 103244. https://doi.org/https://doi.org/10.1016/j.etap.2019.103244
- Özaslan, M. S., Demir, Y., Aslan, H. E., Beydemir, Ş., & Küfrevioğlu, Ö. İ. (2018). Evaluation of chalcones as inhibitors of glutathione S-transferase. Journal of Biochemical and Molecular Toxicology, 32(5), e22047. https://doi.org/https://doi.org/10.1002/jbt.22047
- Pizzino, G., Irrera, N., Cucinotta, M., Pallio, G., Mannino, F., Arcoraci, V., Squadrito, F., Altavilla, D., Bitto, A. (2017). Oxidative stress: Harms and benefits for human health. Oxidative Medicine and Cellular Longevity, 2017, 8416763. https://doi.org/https://doi.org/10.1155/2017/8416763
- Renault, F., Chabrière, E., Andrieu, J.-P., Dublet, B., Masson, P., & Rochu, D. (2006). Tandem purification of two HDL-associated partner proteins in human plasma, paraoxonase (PON1) and phosphate binding protein (HPBP) using hydroxyapatite chromatography. Journal of Chromatography B, 836(1–2), 15–21. https://doi.org/https://doi.org/10.1016/j.jchromb.2006.03.029
- Rozenberg, O., Shih, D. M., & Aviram, M. (2003). Human serum paraoxonase 1 decreases macrophage cholesterol biosynthesis: Possible role for its phospholipase-A2-like activity and lysophosphatidylcholine formation. Arteriosclerosis, Thrombosis, and Vascular Biology, 23(3), 461–467. https://doi.org/https://doi.org/10.1161/01.ATV.0000060462.35946.B3
- Sastry, G. M., Adzhigirey, M., Day, T., Annabhimoju, R., & Sherman, W. (2013). Protein and ligand preparation: Parameters, protocols, and influence on virtual screening enrichments. Journal of Computer-Aided Molecular Design, 27(3), 221–234. https://doi.org/https://doi.org/10.1007/s10822-013-9644-8
- Scholtz, A. W., Schwarz, M., Baumann, W., Kleinfeldt, D., & Scholtz, H.-J. (2004). Treatment of vertigo due to acute unilateral vestibular loss with a fixed combination of cinnarizine and dimenhydrinate: A double-blind, randomized, parallel-group clinical study. Clinical Therapeutics, 26(6), 866–877. https://doi.org/https://doi.org/10.1016/S0149-2918(04)90130-0
- Shelley, J. C., Cholleti, A., Frye, L. L., Greenwood, J. R., Timlin, M. R., & Uchimaya, M. (2007). Epik: A software program for pK a prediction and protonation state generation for drug-like molecules. Journal of Computer-Aided Molecular Design, 21(12), 681–691. https://doi.org/https://doi.org/10.1007/s10822-007-9133-z
- Søgaard, B., Mengel, H., Rao, N., & Larsen, F. (2005). The pharmacokinetics of escitalopram after oral and intravenous administration of single and multiple doses to healthy subjects. The Journal of Clinical Pharmacology, 45(12), 1400–1406. https://doi.org/https://doi.org/10.1177/0091270005280860
- Taslimi, P., Işık, M., Türkan, F., Durgun, M., Türkeş, C., Gülçin, İ., & Beydemir, Ş. (2020). Benzenesulfonamide derivatives as potent acetylcholinesterase, α-glycosidase, and glutathione S-transferase inhibitors: Biological evaluation and molecular docking studies. Journal of Biomolecular Structure and Dynamics. https://doi.org/https://doi.org/10.1080/07391102.2020.1790422
- Taslimi, P., Aslan, H. E., Demir, Y., Oztaskin, N., Maraş, A., Gulçin, İ., Beydemir, S., & Goksu, S. (2018). Diarylmethanon, bromophenol and diarylmethane compounds: Discovery of potent aldose reductase, α-amylase and α-glycosidase inhibitors as new therapeutic approach in diabetes and functional hyperglycemia. International Journal of Biological Macromolecules, 119, 857–863. https://doi.org/https://doi.org/10.1016/j.ijbiomac.2018.08.004
- Taslimi, P., Kandemir, F. M., Demir, Y., İleritürk, M., Temel, Y., Caglayan, C., & Gulçin, İ. (2019). The antidiabetic and anticholinergic effects of chrysin on cyclophosphamide-induced multiple organ toxicity in rats: Pharmacological evaluation of some metabolic enzyme activities . Journal of Biochemical and Molecular Toxicology, 33(6), e22313. https://doi.org/https://doi.org/10.1002/jbt.22313
- Teleb, M., Rizk, O. H., Zhang, F.-X., Fronczek, F. R., Zamponi, G. W., & Fahmy, H. (2019). Design, synthesis and pharmacological evaluation of some substituted dihydropyrimidines with L-/T-type calcium channel blocking activities. Bioorganic Chemistry, 83, 354–366. https://doi.org/https://doi.org/10.1016/j.bioorg.2018.10.054
- Timmer, C. J., Sitsen, J. M. A., & Delbressine, L. P. (2000). Clinical pharmacokinetics of mirtazapine. Clinical Pharmacokinetics, 38(6), 461–474. https://doi.org/https://doi.org/10.2165/00003088-200038060-00001
- Türkan, F., Huyut, Z., Demir, Y., Ertaş, F., & Beydemir, Ş. (2019). The effects of some cephalosporins on acetylcholinesterase and glutathione S-transferase: An in vivo and in vitro study. Archives of Physiology and Biochemistry, 125(3), 235–243. https://doi.org/https://doi.org/10.1080/13813455.2018.1452037
- Türkeş, C. (2019a). Inhibition effects of phenolic compounds on human serum paraoxonase-1 enzyme. Journal of the Institute of Science and Technology, 9(2), 1013–1022. https://doi.org/https://doi.org/10.21597/jist.491054
- Türkeş, C. (2019b). Investigation of potential paraoxonase-I inhibitors by kinetic and molecular docking studies: Chemotherapeutic drugs. Protein and Peptide Letters, 26(6), 392–402. https://doi.org/https://doi.org/10.2174/0929866526666190226162225
- Türkeş, C. (2019c). A potential risk factor for paraoxonase 1: In silico and in-vitro analysis of the biological activity of proton-pump inhibitors . The Journal of Pharmacy and Pharmacology, 71(10), 1553–1564. https://doi.org/https://doi.org/10.1111/jphp.13141
- Türkeş, C., Arslan, M., Demir, Y., Çoçaj, L., Rifati Nixha, A., & Beydemir, Ş. (2019a). Synthesis, biological evaluation and in silico studies of novel N-substituted phthalazine sulfonamide compounds as potent carbonic anhydrase and acetylcholinesterase inhibitors. Bioorganic Chemistry, 89, 103004. https://doi.org/https://doi.org/10.1016/j.bioorg.2019.103004
- Türkeş, C., & Beydemir, Ş. (2020). Inhibition of human serum paraoxonase-I with antimycotic drugs: In vitro and in silico studies. Applied Biochemistry and Biotechnology, 190(1), 252–269. https://doi.org/https://doi.org/10.1007/s12010-019-03073-3
- Türkeş, C., Beydemir, Ş., & Küfrevioğlu, Ö. İ. (2019b). In vitro and in silico studies on the toxic effects of antibacterial drugs as human serum paraoxonase 1 inhibitor. ChemistrySelect, 4(33), 9731–9736. https://doi.org/https://doi.org/10.1002/slct.201902424
- Türkeş, C., Demir, Y., & Beydemir, Ş. (2019c). Anti-diabetic properties of calcium channel blockers: Inhibition effects on aldose reductase enzyme activity. Applied Biochemistry and Biotechnology, 189(1), 318–329. https://doi.org/https://doi.org/10.1007/s12010-019-03009-x
- Türkeş, C., Demir, Y., & Beydemir, Ş. (2020). Calcium Channel Blockers: Molecular Docking and Inhibition Studies on Carbonic Anhydrase I and II Isoenzymes. Journal of Biomolecular Structure and Dynamics, 1–15. https://doi.org/https://doi.org/10.1080/07391102.2020.1736631
- Türkeş, C., Söyüt, H., & Beydemir, Ş. (2013). Inhibition effects of gemcitabine hydrochloride, acyclovir, and 5-fluorouracil on human serum paraoxonase-1 (hPON1): In vitro. Open Journal of Biochemistry, 1, 10–15.
- Türkeş, C., Söyüt, H., & Beydemir, Ş. (2014). Effect of calcium channel blockers on paraoxonase-1 (PON1) activity and oxidative stress. Pharmacological Reports : PR, 66(1), 74–80. https://doi.org/https://doi.org/10.1016/j.pharep.2013.08.007
- Türkeş, C., Söyüt, H., & Beydemir, Ş. (2015). Human serum paraoxonase-1 (hPON1): In vitro inhibition effects of moxifloxacin hydrochloride, levofloxacin hemihidrate, cefepime hydrochloride, cefotaxime sodium and ceftizoxime sodium. Journal of Enzyme Inhibition and Medicinal Chemistry, 30(4), 622–628. https://doi.org/https://doi.org/10.3109/14756366.2014.959511
- Türkeş, C., Söyüt, H., & Beydemir, Ş. (2016). In vitro inhibitory effects of palonosetron hydrochloride, bevacizumab and cyclophosphamide on purified paraoxonase-I (hPON1) from human serum. Environmental Toxicology and Pharmacology, 42, 252–257. https://doi.org/https://doi.org/10.1016/j.etap.2015.11.024
- Valko, M., Leibfritz, D., Moncol, J., Cronin, M. T. D., Mazur, M., & Telser, J. (2007). Free radicals and antioxidants in normal physiological functions and human disease. The International Journal of Biochemistry & Cell Biology, 39(1), 44–84. https://doi.org/https://doi.org/10.1016/j.biocel.2006.07.001
- Zamponi, G. W., Striessnig, J., Koschak, A., & Dolphin, A. C. (2015). The physiology, pathology, and pharmacology of voltage-gated calcium channels and their future therapeutic potential. Pharmacological Reviews, 67(4), 821–870. https://doi.org/https://doi.org/10.1124/pr.114.009654